Oscar Health, Inc. (NYSE:OSCR – Get Free Report) insider Mario Schlosser sold 390,405 shares of the company’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $7.12, for a total transaction of $2,779,683.60. Following the completion of the transaction, the insider now owns 57,317 shares of the company’s stock, valued at $408,097.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Oscar Health Stock Performance
Shares of NYSE:OSCR opened at $8.28 on Tuesday. The company has a market cap of $1.87 billion, a price-to-earnings ratio of -5.21 and a beta of 1.10. The company has a 50-day moving average price of $5.80 and a 200-day moving average price of $6.96. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.32. Oscar Health, Inc. has a 12 month low of $2.05 and a 12 month high of $9.89.
Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings data on Tuesday, November 7th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.18. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. Oscar Health had a negative net margin of 6.39% and a negative return on equity of 37.51%. The company’s quarterly revenue was up 47.2% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.91) earnings per share. As a group, equities analysts anticipate that Oscar Health, Inc. will post -1.3 EPS for the current year.
Hedge Funds Weigh In On Oscar Health
Wall Street Analyst Weigh In
Several analysts have issued reports on the stock. Morgan Stanley upped their price target on shares of Oscar Health from $5.00 to $7.50 and gave the company an “equal weight” rating in a research report on Wednesday, August 30th. The Goldman Sachs Group upped their price target on shares of Oscar Health from $5.50 to $7.50 and gave the company a “neutral” rating in a research report on Thursday, August 10th. Bank of America upgraded shares of Oscar Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $8.00 to $9.00 in a research report on Thursday, November 2nd. Finally, Credit Suisse Group upped their price target on shares of Oscar Health from $7.00 to $8.50 and gave the company an “outperform” rating in a research report on Wednesday, August 9th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $7.70.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.
- Five stocks we like better than Oscar Health
- How to Invest in Grocery Stores
- The most upgraded stocks in November have two things in common
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Monday.com rocked earnings like it’s the weekend
- High Flyers: 3 Natural Gas Stocks for March 2022
- Plan to own one retailer? Make it this one
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.